A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO)
Author(s) -
Agnes M. Rash,
Thomas R. Downes,
Ralf Pörtner,
W W Yeo,
Natalie Morgan,
Kevin S. Channer
Publication year - 2006
Publication title -
age and ageing
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.014
H-Index - 143
eISSN - 1468-2834
pISSN - 0002-0729
DOI - 10.1093/ageing/afl129
Subject(s) - medicine , warfarin , aspirin , atrial fibrillation , stroke (engine) , adverse effect , population , randomized controlled trial , anesthesia , cardiology , mechanical engineering , environmental health , engineering
atrial fibrillation (AF) is the commonest chronic arrhythmia with a prevalence of 9% in octogenarians and accounts for 24% of the stroke risk in this population. Although trials demonstrate reductions in stroke with warfarin, audit data show that it is still underused. However, anti-coagulation in the very elderly is not without risk.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom